期刊文献+

无金属催化合成2,6-二氯嘌呤核苷和2-氯腺苷

Metal-free Synthesis of 2,6-Dichloropurineside and 2-Chloroadenosine
下载PDF
导出
摘要 提出了合成2,6-二氯嘌呤核苷和2-氯腺苷的新方法。以商品化的2,6-二氯嘌呤和四乙酰核糖为原料,在5%(摩尔分数)三氟甲磺酸催化下,得到缩合物2',3',5'-三-O-乙酰基-2,6-二氯嘌呤核苷。缩合物在浓H_2SO_4催化下,以89%的收率得到2,6-二氯嘌呤核苷;在NH_3/CH_3OH体系中氨解和脱除乙酰基,以92%的收率得到2-氯腺苷。反应规模可以扩大到100 g,收率未降低。该方法原料价格低廉,避免使用重金属催化剂,操作简便,中间体及产物可以通过结晶的方法纯化得到,显示出潜在的应用价值。 New methods for the synthesis of 2,6-dichloropurineside and 2-chloroadenosine were developed. The key intermediate 2',3',5'-tri-O-acetyl-2,6-dichloropurineside was obtained from the condensation of 2,6-dichloropurine and β-D-ribofuranose 1,2,3,5-tetraacetate under the catalysis of 5% molar fraction of trifluoromethanesulfonic acid. 2,6-Dichloropurineside was obtained by sulfuric acid catalyzed hydrolysis of 2',3',5'-tri-O-acetyl-2,6-dichloropurineside in the yield of 89% and 2-chloroadenosine was obtained from the aminolysis of 2',3',5'-tri-O-acetyl-2,6-dichloropurineside in NH3/CH3OH with the yield of 92%. The starting substrates were all commercially available and affordable. The presented method avoided toxic metal catalysts and chromatography. Moreover, 2-thioadenosine was obtained in reliable yield on a 100 g scale.
出处 《应用化学》 CAS CSCD 北大核心 2015年第12期1398-1401,共4页 Chinese Journal of Applied Chemistry
基金 国家自然科学基金(21372066)资助项目~~
关键词 二氯嘌呤核苷 氯腺苷 无金属催化 二氯嘌呤 dichloropurineside chloroadenosine metal-free dichloropurine
  • 相关文献

参考文献13

  • 1Schaeffer H,Thomas H. Synthesis of Potential Anticancer Agents. XI V. Ribosides of 2,6-Disubstituted Purines[ J ]. J Am Chem Soc, 1958,80(14) :3738-3742.
  • 2Kumar V,Chhibber S. Intravenous 2-Chloroadenosine Protects BALB/c Mice from Klebsiella Pneumoniae B5055-induced Sepsis by Modulating the Pro-inflammatory Immune Response [ J ]. Curr Microbiol, 2009,59 (3) :274-281.
  • 3Patinha D, Monso J, Sousa T,et al. Activation of Adenosine Receptors Improves Renal Antioxidant Status in Diabetic Wistar but not SHR Rats [ J ]. Ups J Med Sci,2014,119 ( 1 ) : 10-18.
  • 4Bellezza I,Agostini M, Liguori L. Cytostatic Effect of the Nucleoside Analogue 2-Chloroadenosine on Human Prostate Cancer Cell Line [ J ]. Curr Pharm Anal,2005,1 (3) :265-272.
  • 5Marumoto R, Yoshioka Y, Miyashita O, et al. Synthesis and Coronary Vasodilating Activity of 2-Substituted Adenosines [ J ]. Chem Pharm Bull, 1975,23 (4) :759-774.
  • 6Xu S, Yao P, Chen G R,et al. A New Synthesis of 2-chloro-2-Deoxyadenosine(CLADRIBINE), CDA)[ J ]. Nucleos Nucleot Nucl,2011,30(5 ) :353-359.
  • 7夏然,郭真,秦博文,汲智越,谢明胜,渠桂荣,郭海明.一种新的合成氯法拉滨的方法[J].有机化学,2014,34(6):1154-1160. 被引量:2
  • 8Brown G, Weliky V. 2 -Chloroadenine and 2 -Chloroadenosine [ J ]. J Org Chem, 1958,23 ( 1 ) : 125-126.
  • 9申艳红,张文生,冯峰,渠桂荣.2-氯腺苷的合成路线研究[J].精细与专用化学品,2007,15(12):14-15. 被引量:3
  • 10Xia R, Xie M S, Niu H Y, et al. Efficient Synthesis of Nebularine and Vidarabine via Dehydrazination of (Hetero)aromatics Catalyzed by CuSO4 in Water[ J]. Green Chem,2014,16(3) :1077-1081.

二级参考文献48

  • 1朱峰,刘新光,梁念慈.三种腺苷类似物抑制人高转移卵巢癌细胞侵袭的实验研究[J].癌症,2004,23(12):1646-1650. 被引量:5
  • 2[2]Bellezza I,Agostini M,Liguori Lavinia,et al.Cytostatic effect of the nucleoside analogue 2-chloroadenosine on human prostate cancer cell line[J].Current Pharmaceutical Analysis,2005,1(3):265~272
  • 3[4]Lioux T,Gosselin G,Mathe C.Azido/tetrazole tautomerism in 2-azidoadenine-D-pentofurano-nucleoside derivatives[J].European Journal of Organic Chemistry,2003,(20):3997~4002
  • 4[5]Bosworth G,Welliky VS.2-Chloroadenine and 2-chloroadenosine[J].J Org Chem,1958,23(1):125~126
  • 5[6]Marumoto Ri,Yoshioka Y,Miyashita O,et al.Synthesis and coronary vasodilating activity of 2-substituted adenosines[J].Chemical & Pharmaceutical Bulletin,1975,23(4):759~774
  • 6[7]Sampath U,Bartlett L.Process for preparing 2-halo-6-aminonucleosides via halogenation of 2,6-diaminopurine derivatives[P].US 6252061.2001-01-26
  • 7McKenzie S,Frew R,Bar H.Characteristics of the Relaxant Response of Adenosine and its Analogs in Intestinal Smooth Muscle[J].European Journal of Pharmacology,1977,41(2):183-192.
  • 8Sollevi A.Cardiovascular Effects of Adenosine in Man; Possible Clinical Implications[J].Progress in Neurobiology (Oxford,United Kingdom),1986,27 (4):319-349.
  • 9Thomas C,Chan K,Young B.Modulation of the Activity of PALA by dipyrida mole[J].Cancer Treat Res,1985,69(4):425-430.
  • 10Elzein E Palle V,Wu Y.2-Pyrazolyl-N6-substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists[J].Journal of Medicinal Chemistry,2004,47 (19):4 766-4 773.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部